China Resources Medical Holdings (1515) disclosed an updated version of its Nomination Committee Terms of Reference. According to the announcement, the Committee is required to have at least three members, with at least one director of a different gender. A majority of the members must be independent non-executive directors, and the chairman of the Committee can be either the Board chairman or an independent non-executive director.

The quorum for Committee meetings is two members, and resolutions are passed by a majority vote among those present. The Committee will convene at least once a year to review the Board’s composition and skill sets, make relevant recommendations to the Board, and assess director independence, time commitment, and other qualifications. Amendments to the Terms of Reference were last adopted on November 7, 2025, and the Committee has the authority to seek information from senior management and obtain outside professional advice at the Company’s expense, ensuring sufficient resources to fulfill its responsibilities.